Hyperacute Renal Allograft Rejection in the Primate Intrarenal Effects of Heparin and Associated Net Release of Factor VIII Activity and Kallikrein Activation

G. Busch,K. Kobayashi,N. Hollenberg,A. Birtch,R. Colman

Abstract:Two groups of specifically presensitized Macaca speciosa monkeys received renal al- lografts via anastomosis to an indwelling arteriovenous (A-V) shunt. One group was pretreated with heparin (2 mg/kg) intravenously and the other was also treated with constant heparin infusion (1 mg/kg/hr) directly into the renal artery. These studies were performed to evaluate the effects of heparin within the kidney on total and com- partmental blood flow, complement (C3) levels, sequestration of formed elements, and activation of the coagulation, fibrinolytic, and kinin-forming systems during the initial 3 hours of hyperacute rejection. The results are compared with those previously reported in unmodified control allografts. Heparin prolonged blood clotting time to infinity, markedly prolonged total renal venous blood flow, and normalized compartmental distribution in both groups despite antibody deposition similar to that in controls. With heparin pretreatment only, initial morphologic injury was much reduced but then progressed rapidly. Marked initial cortical cyanosis with mottling appeared to change constantly and was associated with fluctuations in renal turgor, total blood flow, and sequestration of formed elements, all of which suggested repetitive local cortical arterial spasm and incremental destruction of the grafts. Activation of coagulation Factors II and XII was also revealed, and marked net Factor VIII activity was observed in the venous effluent. The latter reflects either formation and release of this factor by the injured kidney, or provides in vivo documentation of the "hyperactivation" of Factor VIII by thrombin known to occur in vitro. The addition of intrarenal artery heparin infusion resulted in greater improvement in early total blood flow rates and more jury suggested more uniform perfusion of injured areas. Intrarenal consumption of C3 and sequestration of formed elements was similar to that in controls. Paradoxically, prompt activation and consumption of all coagulation factors, plasminogen, and prekallikrein were observed, but formed fibrin was sparse. The excess amount of Factor XIIa present during heparin blockade may have been diverted to production of plasminogen activator and kallikrein formation. The enormous numbers of neutrophils observed within vessels of grafts which showed the greatest kallikrein activation provide the probable in vivo demonstration of the chemotactic properties of kallikrein noted by others in vitro. Heparin-induced platelet aggregation may have played an important role in the failure of these grafts. These studies elucidate the intrarenal effects of heparin during hyperacute rejection and again suggest th'at vasoconstriction is the most important early determinant of graft failure, as blood flow appeared unrelated to the degree of vascular injury and apparent obstruction. Also, heparin may exert a beneficial effect on blood flow by other than its known action on coagulation. (Am J Pathol 80:1-20, 1975). jection of 15-I, diameter microspheres (2 to 3 X 104) labeled with strontium-85 and ceritm-141 into the uninterrupted arterial limb of the shunt at 5 and 30 minuites respec- tively, after transplantation. Following removal of the grafted kidneys, multiple, weighed, coronal slices of outer and inner cortex and meduilla were evaluated for microsphere se-qtuestration.Renal biopsies, obtained at zero time and 10, 30, 60, 120, and 180 minutes after transplantation or at the time of graft removal because of failure, were processed for rotutine (H &E, PAS) light microscopy and for immunofluiorescent staining with goat an- tihtuman IgG, IgM, IgA, C3, fibrinogen, and albumin (Hyland Laboratories). The serial renal arterial and venous blood samples were evaluiated for serum comple- ment (C3) levels by radial immunodiffuision using Immunoplates (Hyland Laboratories), as well as for hematocrit levels, white blood cell and platelet counts, and coaguilation Fac- tor II, VIII, X, and XII levels. Plasminogen, prekallikrein, and kallikrein inhibitor levels were also measuired. Results of these serial determinations were then expressed as percent normal for each animal, using its own zero time arterial level as the 100% of normal value. Methodology for the above proceduires was identical to that reported previously.4